AIM
NEOS

Alambic Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Alambic Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-24,689
Closed -$19K – 210
2020
Q1 		$19K Sell
24,689
-27,044
-52% -$37.2K 0.05% 182
2019
Q4 		$78K Sell
51,733
-11,700
-18% -$17.6K 0.07% 256
2019
Q3 		$94K Sell
63,433
-155,657
-71% -$252K 0.07% 267
2019
Q2 		$283K Buy
219,090
+206,990
+1,711% +$381K 0.17% 202
2019
Q1 		$32K Buy
+12,100
New +$28.4K 0.01% 339

Other funds holding NEOS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alambic Investment Management's NEOS Position: Q2 2020 in Review

Alambic Investment Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2020, closing a stake of 24,689 shares — an estimated $19K sold.

Alambic Investment Management first reported a position in NEOS in Q1 2019 and held it in 5 quarters. The position peaked at $283K in Q2 2019. 44 funds tracked by Wall St. Rank hold NEOS as of Q2 2020.

  • Alambic Investment Management reported no remaining Neos Therapeutics, Inc position as of Q2 2020 after selling out during the quarter.
  • Alambic Investment Management sold 24,689 Neos Therapeutics, Inc shares in Q2 2020, an estimated $19K.
  • Alambic Investment Management first reported a position in Neos Therapeutics, Inc in Q1 2019 and held it in 5 quarters.
  • Alambic Investment Management's Neos Therapeutics, Inc position peaked at $283K in Q2 2019.
  • 44 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2020.

Based on Alambic Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.